Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
recurrence
,
neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
Eribulin
recurrence
,
breast neoplasms
,
neoplasms
Eribulin mesylate
recurrence
,
breast neoplasms
,
neoplasms
Angiotensin ii
healthy volunteers/patients
,
hypertrophic cardiomyopathy
,
cardiomyopathies
,
headache
,
cluster headache
,
diabetic retinopathy
,
breast neoplasms
,
hyperkalemia
,
migraine disorders
,
migraine without aura
,
migraine with aura
,
aortic valve stenosis
,
pathologic constriction
,
cardiotoxicity
,
retinal diseases
,
proteinuria
,
atrial fibrillation
,
stroke
,
chronic renal insufficiency
,
renal insufficiency
,
hypertension
,
heart failure
,
type 2 diabetes mellitus
,
diabetes mellitus
,
type 1 diabetes mellitus
,
hypertrophy
,
obesity
,
kidney diseases
,
left ventricular dysfunction
,
ventricular dysfunction
,
left ventricular hypertrophy
,
glucose intolerance
,
cohort studies
,
essential hypertension
,
diabetic nephropathies
Mycophenolate sodium
hyperlipoproteinemia type i
Docusate
chronic renal insufficiency
,
hypertension
,
kidney diseases
,
hyperkalemia
Mycophenolic acid
hyperlipoproteinemia type i
Iron dextran
colorectal neoplasms
,
colonic neoplasms
,
heart failure
,
anemia
,
iron-deficiency anemia
,
iron deficiencies
Sintilimab
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
Penpulimab
squamous cell carcinoma
,
colorectal neoplasms
,
stomach neoplasms
,
pancreatic neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma of head and neck
,
large b-cell lymphoma diffuse
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
thyroid neoplasms
,
breast neoplasms
,
sarcoma
,
rectal neoplasms
,
b-cell lymphoma
,
pheochromocytoma
,
urologic neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
small cell lung carcinoma
,
female genital neoplasms
,
glioblastoma
,
uterine cervical neoplasms
,
neoplasms by histologic type
,
triple negative breast neoplasms
,
male breast neoplasms
,
essential tremor
,
head and neck neoplasms
,
syndrome
,
gastrointestinal diseases
,
digestive system diseases
,
recurrence
,
paraganglioma
,
osteosarcoma
,
melanoma
,
esophageal neoplasms
,
neoplasm metastasis
,
carcinoma
,
neoplasms
,
lung neoplasms
,
lymphoma
,
nasopharyngeal carcinoma
,
hepatocellular carcinoma
,
nasopharyngeal neoplasms
,
liver neoplasms
,
hodgkin disease
,
squamous cell neoplasms
,
adenocarcinoma
,
hypersensitivity
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
small cell carcinoma
,
thyroid diseases
Lanifibranor
healthy volunteers/patients
,
pharmacokinetics
,
type 2 diabetes mellitus
,
diabetes mellitus
,
liver diseases
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
non-alcoholic fatty liver disease
,
fatty liver
,
fibrosis
Gilvetmab
parkinson disease
,
shy-drager syndrome
,
multiple system atrophy
,
lewy body disease
,
dementia
,
synucleinopathies
,
progressive supranuclear palsy
,
corticobasal degeneration
Enoblituzumab
depressive disorder
,
breast neoplasms
,
mumps
,
rubella
,
measles
,
infections
,
papillomavirus infections
,
papillomavirus vaccines
,
neisseria meningitidis
,
haemophilus influenzae type b
,
hepatitis
,
hepatitis a
,
covid-19
,
migraine disorders
,
prostatic hyperplasia
,
hyperplasia
,
muscle spasticity
,
epilepsy
,
financial stress
,
herpes zoster
,
herpes simplex
Efbemalenograstim alfa
non-small-cell lung carcinoma
,
lung neoplasms
,
febrile neutropenia
,
colorectal neoplasms
,
pancreatic neoplasms
,
ovarian neoplasms
,
uterine cervical neoplasms
,
neutropenia
,
breast neoplasms
,
neoplasms
Aglatimagene besadenovec
lymphoma
,
triple negative breast neoplasms
,
pharmacokinetics
,
healthy volunteers/patients
,
pharmacological phenomena
,
neoplasms
,
breast neoplasms
,
adenocarcinoma
,
neoplasm metastasis
,
carcinoma
,
ovarian neoplasms
,
non-small-cell lung carcinoma
,
pancreatic neoplasms
,
colorectal neoplasms
,
lung neoplasms
,
uterine cervical neoplasms
,
endometrial neoplasms
,
stomach neoplasms
,
urinary bladder neoplasms
,
small cell lung carcinoma
,
biliary tract neoplasms
,
bone neoplasms
,
bone diseases
,
hereditary breast and ovarian cancer syndrome
,
aggression
,
head and neck neoplasms
,
dna repair-deficiency disorders
,
sarcoma
,
ovarian epithelial carcinoma
,
recurrence
,
hypersensitivity
,
gynecomastia
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
heart failure
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
osteoporosis
,
obesity
,
disease susceptibility
,
hepatocellular carcinoma
,
liver neoplasms
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use